ORIGINAL RESEARCH
Published on 15 Oct 2024
Retrospective analysis of survival and safety of bevacizumab biosimilar and original drug combination chemotherapy in non-small cell lung cancer
doi 10.3389/fonc.2024.1437762
- 1,940 views
- 1 citation
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- Targeted Immunometabolic Therapy for Tumors
Targeted Immunometabolic Therapy for Tumors
8,893
Total downloads
36k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 09 Aug 2024
The relationship between metabolite mediated immune regulatory imbalance and the occurrence of malignant tumors of bone and articular cartilage: a Mendelian randomization study
doi 10.3389/fimmu.2024.1433219
- 3,758 views
- 4 citations
REVIEW
Published on 07 May 2024
Current status and breakthroughs in treating advanced non-small cell lung cancer with EGFR exon 20 insertion mutations
doi 10.3389/fimmu.2024.1399975
- 11,440 views
- 12 citations
REVIEW
Published on 26 Mar 2024
Targeting PRAME for acute myeloid leukemia therapy
doi 10.3389/fimmu.2024.1378277
- 5,499 views
- 11 citations
REVIEW
Published on 29 Feb 2024
Checkpoint CD24 function on tumor and immunotherapy
doi 10.3389/fimmu.2024.1367959
- 8,262 views
- 15 citations
Published in
Frontiers in Oncology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Immunology
- 5.9 impact factor
- 10.8 citescore